318 related articles for article (PubMed ID: 29872699)
1. Endothelial cell malignancies: new insights from the laboratory and clinic.
Wagner MJ; Ravi V; Menter DG; Sood AK
NPJ Precis Oncol; 2017; 1(1):11. PubMed ID: 29872699
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell malignancies in infants, children and adolescents: Treatment results of three Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Sparber-Sauer M; Koscielniak E; Vokuhl C; Schmid I; Bien E; Seitz G; Hallmen E; von Kalle T; Scheer M; Münter M; Bielack SS; Niggli F; Ljungman G; Fuchs J; Hettmer S; Rössler J; Klingebiel T;
Pediatr Blood Cancer; 2020 Mar; 67(3):e28095. PubMed ID: 31814291
[TBL] [Abstract][Full Text] [Related]
3. Pathologic Angiogenesis of Malignant Vascular Sarcomas: Implications for Treatment.
Khan JA; Maki RG; Ravi V
J Clin Oncol; 2018 Jan; 36(2):194-201. PubMed ID: 29220293
[TBL] [Abstract][Full Text] [Related]
4. Regulation of angiogenesis in malignancies associated with Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus.
Sakakibara S; Tosato G
Future Microbiol; 2009 Sep; 4(7):903-17. PubMed ID: 19722843
[TBL] [Abstract][Full Text] [Related]
5. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
[TBL] [Abstract][Full Text] [Related]
6. Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells.
Yu Y; Varughese J; Brown LF; Mulliken JB; Bischoff J
Am J Pathol; 2001 Dec; 159(6):2271-80. PubMed ID: 11733376
[TBL] [Abstract][Full Text] [Related]
7. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
8. Primary diagnosis of angiosarcoma by fine needle aspiration: Lessons learned from 3 cases.
Lepe M; Hui Y; Pisharodi L; Canepa M
Diagn Cytopathol; 2018 Apr; 46(4):349-354. PubMed ID: 29087044
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants.
Stratmann A; Acker T; Burger AM; Amann K; Risau W; Plate KH
Int J Cancer; 2001 Feb; 91(3):273-82. PubMed ID: 11169947
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
11. Kaposi Sarcoma-Associated Herpesvirus Glycoprotein H Is Indispensable for Infection of Epithelial, Endothelial, and Fibroblast Cell Types.
Muniraju M; Mutsvunguma LZ; Foley J; Escalante GM; Rodriguez E; Nabiee R; Totonchy J; Mulama DH; Nyagol J; Wussow F; Barasa AK; Brehm M; Ogembo JG
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142670
[TBL] [Abstract][Full Text] [Related]
12. Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma.
Brown LF; Dezube BJ; Tognazzi K; Dvorak HF; Yancopoulos GD
Am J Pathol; 2000 Jun; 156(6):2179-83. PubMed ID: 10854238
[TBL] [Abstract][Full Text] [Related]
13. The vascular endothelial growth factor (VEGF) signaling pathway: a therapeutic target in patients with hematologic malignancies.
Giles FJ
Oncologist; 2001; 6 Suppl 5():32-9. PubMed ID: 11700390
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction targets in Kaposi's sarcoma.
Sullivan R; Dezube BJ; Koon HB
Curr Opin Oncol; 2006 Sep; 18(5):456-62. PubMed ID: 16894293
[TBL] [Abstract][Full Text] [Related]
15. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
[TBL] [Abstract][Full Text] [Related]
16. SUMOylation Negatively Regulates Angiogenesis by Targeting Endothelial NOTCH Signaling.
Zhu X; Ding S; Qiu C; Shi Y; Song L; Wang Y; Wang Y; Li J; Wang Y; Sun Y; Qin L; Chen J; Simons M; Min W; Yu L
Circ Res; 2017 Sep; 121(6):636-649. PubMed ID: 28760777
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in health and disease: insights into basic mechanisms and therapeutic opportunities.
Polverini PJ
J Dent Educ; 2002 Aug; 66(8):962-75. PubMed ID: 12214844
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
[TBL] [Abstract][Full Text] [Related]
19. All-trans retinoic acid induces in vitro angiogenesis via retinoic acid receptor: possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling.
Saito A; Sugawara A; Uruno A; Kudo M; Kagechika H; Sato Y; Owada Y; Kondo H; Sato M; Kurabayashi M; Imaizumi M; Tsuchiya S; Ito S
Endocrinology; 2007 Mar; 148(3):1412-23. PubMed ID: 17170094
[TBL] [Abstract][Full Text] [Related]
20. Compensatory angiogenesis and tumor refractoriness.
Gacche RN
Oncogenesis; 2015 Jun; 4(6):e153. PubMed ID: 26029827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
